Intraoperative Sonographically Guided Resection of Non-enhancing Gliomas
NCT ID: NCT05470374
Last Updated: 2025-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
96 participants
INTERVENTIONAL
2022-09-01
2027-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sonography-guided Resection of Brain Mass Lesions
NCT05484245
General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas
NCT05485038
Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
NCT05873946
Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
NCT02795364
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
NCT02379572
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective of the study is to determine whether intraoperative ultrasound guided resection of non-enhancing gliomas can achieve higher extent of resection than surgery without intraoperative sonography.
Participants of the study will be randomly operated with and without intraoperative ultrasound. Extent of resection will be assessed in postoperative MRI by blinded radiologists.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ultrasound
Glioma resection with intraoperative sonography
Intraoperative sonography
ultrasound scanning of brain to search tumor remnants
Non-ultrasound
Glioma resection without intraoperative sonography
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intraoperative sonography
ultrasound scanning of brain to search tumor remnants
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* newly diagnosed
* previously untreated
* Karnofsky Performance Status 60-100%
* age 18-79 years
* performed magnetic resonance imaging with contrast enhancement
Exclusion Criteria
* previously performed radiotherapy, chemotherapy or immunotherapy
* planned supratotal tumor resection until neurophysiologically revealed eloquent areas
18 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sklifosovsky Institute of Emergency Care
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexander Dmitriev
Neurosurgeon, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Dmitriev, MD
Role: PRINCIPAL_INVESTIGATOR
Sklifosovsky Institute of Emergency Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sklifosovsky Institute of Emergency Care
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.